Medicamen Biotech Limited (MEDICAMEQ.BO)

INR 562.7

(1.74%)

Revenue Summary of Medicamen Biotech Limited

  • Medicamen Biotech Limited's latest annual revenue in 2023 was 1.79 Billion INR , up 27.29% from previous year.
  • Medicamen Biotech Limited's latest quarterly revenue in 2024 Q1 was 430.48 Million INR , down -9.03% from previous quarter.
  • Medicamen Biotech Limited reported a annual revenue of 1.4 Billion INR in annual revenue 2022, up 22.02% from previous year.
  • Medicamen Biotech Limited reported a annual revenue of 1.15 Billion INR in annual revenue 2021, up 2.42% from previous year.
  • Medicamen Biotech Limited reported a quarterly revenue of 1.79 Billion INR for 2023 FY, up 27.29% from previous quarter.
  • Medicamen Biotech Limited reported a quarterly revenue of 419.43 Million INR for 2023 Q1, up 8.48% from previous quarter.

Annual Revenue Chart of Medicamen Biotech Limited (2023 - 2007)

Historical Annual Revenue of Medicamen Biotech Limited (2023 - 2007)

Year Revenue Revenue Growth
2023 1.79 Billion INR 27.29%
2022 1.4 Billion INR 22.02%
2021 1.15 Billion INR 2.42%
2020 1.12 Billion INR -10.19%
2019 1.25 Billion INR 2.36%
2018 1.22 Billion INR 9.95%
2017 1.11 Billion INR 35.23%
2016 824.55 Million INR 22.56%
2015 672.75 Million INR -13.52%
2014 777.93 Million INR 6.21%
2013 732.48 Million INR 14.45%
2012 639.97 Million INR -36.34%
2011 1 Billion INR -18.25%
2010 1.22 Billion INR 21.02%
2009 1.01 Billion INR 17.69%
2008 863.35 Million INR 12.22%
2007 769.32 Million INR 0.0%

Peer Revenue Comparison of Medicamen Biotech Limited

Name Revenue Revenue Difference
Ajanta Pharma Limited 42.08 Billion INR 95.74%
Amrutanjan Health Care Limited 4.21 Billion INR 57.433%
Sigachi Industries Limited 3.98 Billion INR 55.056%
Bal Pharma Limited 3.39 Billion INR 47.142%
Ind-Swift Laboratories Limited 12.8 Billion INR 86.002%
Medico Remedies Limited 1.44 Billion INR -23.727%
Lasa Supergenerics Limited 1.04 Billion INR -71.856%
Venus Remedies Limited 5.91 Billion INR 69.684%
Sun Pharma Advanced Research Company Limited 755.45 Million INR -137.349%
Alpa Laboratories Limited 1.08 Billion INR -64.896%
Nectar Lifesciences Limited 16.84 Billion INR 89.353%
Shilpa Medicare Limited 11.51 Billion INR 84.43%
Aarti Drugs Limited 25.28 Billion INR 92.909%
Lupin Limited 200.1 Billion INR 99.104%
Aurobindo Pharma Limited 287.04 Billion INR 99.375%
Zydus Lifesciences Limited 190.21 Billion INR 99.057%
Windlas Biotech Limited 6.3 Billion INR 71.582%
Suven Life Sciences Limited 116.92 Million INR -1433.462%
Eris Lifesciences Limited 20.09 Billion INR 91.075%
Valiant Laboratories Limited 1.82 Billion INR 1.511%
J. B. Chemicals & Pharmaceuticals Limited 34.84 Billion INR 94.854%
Solara Active Pharma Sciences Limited 12.38 Billion INR 85.521%
Ipca Laboratories Limited 76.22 Billion INR 97.648%
Bliss GVS Pharma Limited 7.7 Billion INR 76.721%
Achyut Healthcare Limited 61.36 Million INR -2821.772%
Sun Pharmaceutical Industries Limited 484.96 Billion INR 99.63%
Bajaj HealthCare Limited 4.73 Billion INR 62.125%
RPG Life Sciences Limited 5.82 Billion INR 69.194%
Mankind Pharma Limited 103.34 Billion INR 98.265%
Laurus Labs Limited 50.01 Billion INR 96.415%
Piramal Pharma Limited 81.71 Billion INR 97.806%
Syncom Formulations (India) Limited 2.59 Billion INR 30.835%
Torrent Pharmaceuticals Limited 106.05 Billion INR 98.309%
Alembic Pharmaceuticals Limited 61.12 Billion INR 97.066%
Glenmark Pharmaceuticals Limited 118.13 Billion INR 98.482%
Unichem Laboratories Limited 16.57 Billion INR 89.182%
Sequent Scientific Limited 13.69 Billion INR 86.909%
Novartis India Limited 3.35 Billion INR 46.487%
Wanbury Limited 5.75 Billion INR 68.852%
Suven Pharmaceuticals Limited 10.51 Billion INR 82.945%
Wockhardt Limited 27.89 Billion INR 93.571%
Themis Medicare Limited 3.81 Billion INR 53.032%
Jagsonpal Pharmaceuticals Limited 2.08 Billion INR 14.085%
Jubilant Pharmova Limited 67.02 Billion INR 97.325%
Glenmark Life Sciences Limited 22.83 Billion INR 92.147%
Dr. Reddy's Laboratories Limited 279.16 Billion INR 99.358%
Divi's Laboratories Limited 78.45 Billion INR 97.714%
NATCO Pharma Limited 40.02 Billion INR 95.52%
Gufic Biosciences Limited 8.06 Billion INR 77.772%
IOL Chemicals and Pharmaceuticals Limited 21.18 Billion INR 91.538%
Ind-Swift Limited 5.02 Billion INR 64.315%
Procter & Gamble Health Limited 11.51 Billion INR 84.425%
FDC Limited 19.42 Billion INR 90.771%
Krebs Biochemicals & Industries Limited 504.21 Million INR -255.615%
Granules India Limited 45.06 Billion INR 96.021%
Alkem Laboratories Limited 126.67 Billion INR 98.585%
AstraZeneca Pharma India Limited 12.95 Billion INR 86.16%
Biofil Chemicals and Pharmaceuticals Limited 400.35 Million INR -347.87%
Brooks Laboratories Limited 794.86 Million INR -125.582%
Megasoft Limited 373.95 Million INR -379.489%
ZIM Laboratories Limited 3.67 Billion INR 51.199%
Strides Pharma Science Limited 40.51 Billion INR 95.574%
Neuland Laboratories Limited 15.58 Billion INR 88.496%
Morepen Laboratories Limited 17.01 Billion INR 89.464%
Hikal Limited 17.84 Billion INR 89.953%
Indoco Remedies Limited 17.89 Billion INR 89.98%
Aarti Pharmalabs Limited 18.15 Billion INR 90.124%
Kilitch Drugs (India) Limited 1.54 Billion INR -16.152%
Mangalam Drugs & Organics Limited 3.68 Billion INR 51.354%
Hester Biosciences Limited 3.04 Billion INR 41.123%